These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32276618)

  • 21. Assessment of Isoniazid Preventive Therapy and Incidence of Tuberculosis among People Living with Human Immunodeficiency Virus Seeking Care in an Anti-retroviral Therapy Center, Puducherry.
    Kannusamy S; Sahu SK; Udayashankar C; Sarveswaran G; Roy G
    Indian J Public Health; 2024 Jan; 68(1):15-20. PubMed ID: 38847627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
    Briggs MA; Emerson C; Modi S; Taylor NK; Date A
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmatic Evaluation of an Algorithm for Intensified Tuberculosis Case Finding and Isoniazid Preventive Therapy for People Living With HIV in Thailand and Vietnam.
    Cowger TL; Thai LH; Duong BD; Danyuttapolchai J; Kittimunkong S; Nhung NV; Nhan DT; Monkongdee P; Thoa CK; Khanh VT; Nateniyom S; Yen NTB; Ngoc DV; Thinh T; Whitehead S; Pevzner ES
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):512-521. PubMed ID: 29023251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Completion of isoniazid preventive therapy for latent tuberculosis infection among children and adolescents compared to adults living with HIV in Kinshasa, Democratic Republic of the Congo.
    Bidashimwa D; Ditekemena JD; Sigwadhi LN; Nkuta LM; Engetele E; Kilundu A; Chabikuli ON; Nachega JB
    Trop Med Int Health; 2024 Feb; 29(2):88-95. PubMed ID: 38123460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
    Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB
    BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi.
    Little KM; Khundi M; Barnes GL; Ngwira LG; Nkhoma A; Makombe S; Corbett EL; Chaisson RE; Dowdy DW
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):371-377. PubMed ID: 29562983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women.
    LaCourse SM; Wagner AD; Cranmer LM; Copeland A; Maleche-Obimbo E; Richardson BA; Matemo D; Kinuthia J; John-Stewart G
    J Acquir Immune Defic Syndr; 2019 Sep; 82(1):41-45. PubMed ID: 31408031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.
    Onyango DO; van der Sande MAB; Yuen CM; Mecha J; Matemo D; Oele E; Kinuthia J; John-Stewart G; LaCourse SM
    J Int AIDS Soc; 2022 Aug; 25(8):e25939. PubMed ID: 35927793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.
    Jacobson KB; Niccolai L; Mtungwa N; Moll AP; Shenoi SV
    AIDS Care; 2017 Jul; 29(7):936-942. PubMed ID: 28147705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with isoniazid preventive treatment interruption and completion among PLHIV in Gombe Hospital, Uganda, 2017-2019.
    Ssendikwanawa E; Juniour Nsubuga E; Lee S; Frances Zalwango J; Joan Bayowa R; Judith Ssemasaazi A; Ronald Muganga K; Adolphus C; Akunzirwe R; Nante Wangi R; Ronald Kasoma M; Kalyango JN; Karamagi C; Sekaggya-Wiltshire C
    J Clin Tuberc Other Mycobact Dis; 2023 May; 31():100349. PubMed ID: 37181458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trend analysis of tuberculosis case notifications with scale-up of antiretroviral therapy and roll-out of isoniazid preventive therapy in Zimbabwe, 2000-2018.
    Takarinda KC; Harries AD; Mutasa-Apollo T; Sandy C; Choto RC; Mabaya S; Mbito C; Timire C
    BMJ Open; 2020 Apr; 10(4):e034721. PubMed ID: 32265241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts.
    Assefa DG; Zeleke ED; Bekele D; Ejigu DA; Molla W; Woldesenbet TT; Aynalem A; Abebe M; Mebratu A; Manyazewal T
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.
    Danyuttapolchai J; Kittimunkong S; Nateniyom S; Painujit S; Klinbuayaem V; Maipanich N; Maokamnerd Y; Pevzner E; Whitehead S; Kanphukiew A; Monkongdee P; Martin M
    PLoS One; 2017; 12(9):e0184986. PubMed ID: 28949995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia.
    Ayele HT; van Mourik MS; Bonten MJ
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1342-1347. PubMed ID: 27725045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya.
    Gersh JK; Barnabas RV; Matemo D; Kinuthia J; Feldman Z; Lacourse SM; Mecha J; Warr AJ; Kamene M; Horne DJ
    BMC Infect Dis; 2021 Feb; 21(1):218. PubMed ID: 33632173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania.
    Zhu J; Lyatuu G; Sudfeld CR; Kiravu A; Sando D; Machumi L; Minde J; Chisonjela F; Cohen T; Menzies NA
    Lancet Glob Health; 2022 Nov; 10(11):e1646-e1654. PubMed ID: 36240830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation and evaluation of an isoniazid preventive therapy pilot program among HIV-infected patients in Vietnam, 2008-2010.
    Trinh TT; Han DT; Bloss E; Le TH; Vu TT; Mai AH; Nguyen NV; Nguyen LT; Dinh SN; Whitehead S
    Trans R Soc Trop Med Hyg; 2015 Oct; 109(10):653-9. PubMed ID: 26385936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoniazid preventive therapy use among adult people living with HIV in Zimbabwe.
    Takamiya M; Takarinda K; Balachandra S; Godfrey M; Radin E; Hakim A; Pearson ML; Choto R; Sandy C; Maphosa T; Rogers JH
    Int J STD AIDS; 2021 Oct; 32(11):1020-1027. PubMed ID: 33978529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.